Back to feed
CNTACentessa Pharmaceuticals plc
CIK 0001847903 · last filing 4d ago · 43 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
43 sell transactions
Net flow
+$0
Net buying
Total flow
$0
43 priced transactions
Disclosure radarcross-source convergence
Activist2/5 sources
34/100
Recent disclosures · timeline
- Schedule 13D2d ago
0.0% stake · passive (13G)
- Form 44d ago
Director · filed
- Form 44d ago
Director · filed
- Form 44d ago
Chief Business Officer · filed
Price · CNTA
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
CNTA insider flow· last 30 days
Buys Sellsnet +$0
No priced transactions in this range.
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data2 funds hold$37.05M reported valueNet accumulating(2 adding · 0 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 625,420 | $24.84M | 0.0% | Add+6% |
| Point72 Asset Management, L.P. Steve Cohen | 307,355 | $12.21M | 0.2% | New |
5%+ stakes · Schedule 13D/G
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
4d ago Jun 24, 2026 | Hedley Mary Lynne Director | Sell · D | 208,474 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Hedley Mary Lynne Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Hedley Mary Lynne Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Hedley Mary Lynne Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Hedley Mary Lynne Director | Sell · D | 40,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | ZBAR BRETT I W Director | Sell · D | 64,570 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | ZBAR BRETT I W Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | ZBAR BRETT I W Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | ZBAR BRETT I W Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | ZBAR BRETT I W Director | Sell · D | 40,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 65,925 | — | — | Neutral+5 | ||
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 584,321 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 230,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 31,002 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 125,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 100,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 123,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Weinhoff Gregory M Chief Business Officer | Sell · D | 319,660 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 4,398,519 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 55,677 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 3,936,970 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | Crowley John J Chief Financial Officer | Sell · D | 45,000 | — | — | Neutral+5 | ||
4d ago Jun 24, 2026 | Crowley John J Chief Financial Officer | Sell · D | 600,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Crowley John J Chief Financial Officer | Sell · D | 250,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Crowley John J Chief Financial Officer | Sell · D | 181,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | INDEX VENTURES LIFE VI (JERSEY) L.P. 10% Owner | Sell · S | 9,812,368 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | INDEX VENTURES LIFE VI (JERSEY) L.P. 10% Owner | Sell · S | 149,421 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 93,526 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 11,197,303 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | De Rubertis Francesco Director | Sell · D | 281,162 | — | — | Neutral+2 | ||
4d ago Jun 24, 2026 | Kanes Stephen Chief Medical Officer | Sell · D | 120,000 | — | — | Neutral+5 | ||
4d ago Jun 24, 2026 | Kanes Stephen Chief Medical Officer | Sell · D | 500,000 | — | — | Neutral+5 | Deriv | |
4d ago Jun 24, 2026 | Kulkarni Samarth Director | Sell · D | 208,474 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Kulkarni Samarth Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Kulkarni Samarth Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Kulkarni Samarth Director | Sell · D | 48,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Kulkarni Samarth Director | Sell · D | 40,000 | — | — | Neutral+2 | Deriv | |
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 4,398,519 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 55,677 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 3,936,970 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 93,526 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 11,197,303 | — | — | Mild sell-17 | ||
4d ago Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | Sell · S | 281,162 | — | — | Mild sell-17 |